Danske Bank’s Privia Health PRVA Stock Holding History

Danske Bank’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40,068	Closed	-$783K	–	1441
2024 Q4	$783K	Sell	40,068 -30,318	-43%	-$601K	﹤0.01%	865
2024 Q3	$1.28M	Buy	+70,386	New	+$1.34M	﹤0.01%	775

Other funds holding PRVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Danske Bank's PRVA Position: Q1 2025 in Review

Danske Bank sold out of Privia Health (PRVA) in Q1 2025, closing a stake of 40,068 shares — an estimated $783K sold.

Danske Bank first reported a position in PRVA in Q3 2024 and held it in 2 quarters. The position peaked at $1.28M in Q3 2024. 248 funds tracked by Wall St. Rank hold PRVA as of Q1 2025.

Danske Bank reported no remaining Privia Health position as of Q1 2025 after selling out during the quarter.
Danske Bank sold 40,068 Privia Health shares in Q1 2025, an estimated $783K.
Danske Bank first reported a position in Privia Health in Q3 2024 and held it in 2 quarters.
Danske Bank's Privia Health position peaked at $1.28M in Q3 2024.
248 funds tracked by Wall St. Rank held Privia Health as of Q1 2025.

Based on Danske Bank's 13F filing for Q1 2025, filed 18 Dec 2025.